APT Medical Inc. (SHA:688617)
China
· Delayed Price · Currency is CNY 230.16
+3.15 (1.39%)
Mar 10, 2026, 11:29 AM CST
APT Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Market Capitalization | 32,015 | 34,308 | 36,094 | 25,854 | 20,463 | 18,668 | Upgrade
|
| Market Cap Growth | -8.74% | -4.95% | 39.61% | 26.35% | 9.62% | - | Upgrade
|
| Enterprise Value | 30,710 | 33,003 | 35,194 | 24,788 | 19,457 | 17,519 | Upgrade
|
| Last Close Price | 227.01 | 243.27 | 255.66 | 183.20 | 144.11 | 130.74 | Upgrade
|
| PE Ratio | 39.01 | 41.81 | 53.62 | 48.42 | 57.16 | 89.78 | Upgrade
|
| Forward PE | 29.28 | 33.30 | 41.69 | 41.48 | 50.33 | 65.88 | Upgrade
|
| PS Ratio | 12.39 | 13.28 | 17.47 | 15.67 | 16.83 | 22.53 | Upgrade
|
| PB Ratio | 10.54 | 11.30 | 14.13 | 13.18 | 11.43 | 10.42 | Upgrade
|
| P/TBV Ratio | 12.56 | 13.46 | 17.47 | 14.56 | 11.87 | 10.69 | Upgrade
|
| P/FCF Ratio | - | - | 387.51 | 53.09 | 91.25 | 1332.38 | Upgrade
|
| P/OCF Ratio | - | - | 48.55 | 37.52 | 55.69 | 102.92 | Upgrade
|
| EV/Sales Ratio | 11.89 | 12.77 | 17.04 | 15.02 | 16.00 | 21.14 | Upgrade
|
| EV/EBITDA Ratio | 30.09 | 32.34 | 44.54 | 42.67 | 47.96 | 86.10 | Upgrade
|
| EV/EBIT Ratio | 32.53 | 34.96 | 49.32 | 47.23 | 53.31 | 99.72 | Upgrade
|
| EV/FCF Ratio | - | - | 377.84 | 50.90 | 86.76 | 1250.43 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.05 | 0.03 | 0.03 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.02 | 0.01 | 0.15 | 0.13 | 0.22 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.12 | 0.19 | 0.24 | 3.32 | Upgrade
|
| Net Debt / Equity Ratio | -0.45 | -0.45 | -0.42 | -0.63 | -0.60 | -0.66 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.33 | -1.33 | -1.35 | -2.15 | -2.66 | -5.78 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -11.48 | -2.56 | -4.81 | -83.99 | Upgrade
|
| Asset Turnover | - | - | 0.74 | 0.69 | 0.57 | 0.64 | Upgrade
|
| Inventory Turnover | - | - | 1.60 | 1.46 | 1.18 | 1.27 | Upgrade
|
| Quick Ratio | - | - | 2.92 | 2.36 | 2.90 | 6.53 | Upgrade
|
| Current Ratio | - | - | 3.98 | 2.99 | 3.78 | 7.98 | Upgrade
|
| Return on Equity (ROE) | 29.35% | 29.35% | 29.14% | 27.82% | 18.99% | 17.39% | Upgrade
|
| Return on Assets (ROA) | - | - | 16.06% | 13.67% | 10.76% | 8.44% | Upgrade
|
| Return on Invested Capital (ROIC) | 49.13% | 52.22% | 57.22% | 64.41% | 47.40% | 31.43% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 27.70% | 26.40% | 20.10% | 9.70% | Upgrade
|
| Earnings Yield | 2.56% | 2.39% | 1.86% | 2.07% | 1.75% | 1.11% | Upgrade
|
| FCF Yield | - | - | 0.26% | 1.88% | 1.10% | 0.07% | Upgrade
|
| Dividend Yield | 0.52% | - | 0.47% | 0.52% | 0.55% | 0.36% | Upgrade
|
| Payout Ratio | - | - | 19.90% | 21.02% | 19.28% | 15.96% | Upgrade
|
| Buyback Yield / Dilution | 0.03% | 0.03% | 0.52% | 0.16% | -2.99% | -31.45% | Upgrade
|
| Total Shareholder Return | 0.56% | 0.03% | 1.00% | 0.68% | -2.44% | -31.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.